在接受活跃癌症治疗的患者中进行数字整合医学干预的随机临床试验
Jun J Mao1, Karolina Bryl2, Erin F Gillespie3
1Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. maoj@mskcc.org.
NPJ digital medicine
|January 14, 2025
概括
一个数字整合医学计划显著减少了癌症患者的疲劳,痛苦,焦虑和抑郁. 它还减少了急诊,住院和住院时间.
科学领域:
- 综合医学是一个整体的医学.
- 数字健康干预措施 数字健康干预措施
- 瘤学 支持性护理 支持性护理
背景情况:
- 运动和正念有望帮助管理与癌症相关的疲劳和症状.
- 对癌症患者进行这些干预措施的数字化交付仍然未经评估.
- 在家整合医疗 (IM@Home) 旨在弥合这一差距.
研究的目的:
- 评估一个为期12周的数字整合医学计划 (IM@Home) 与常规护理的影响.
- 评估对癌症患者疲劳严重程度,并发症症状和急性医疗保健利用的影响.
- 确定整合医学数字方法的可行性和有效性.
主要方法:
- 一项随机对照试验,涉及200名患有固体瘤的患者,他们经历了与治疗相关的疲劳.
- 干预组接受了IM@Home计划;对照组接受了增强的常规护理.
- 测量结果包括疲劳严重程度,症状困扰,焦虑,抑郁和医疗保健利用率.
主要成果:
- 与对照组相比,IM@Home显著降低了疲劳严重程度 (p=0.04).
- 在IM@Home的参与者报告说,症状困扰,焦虑和抑郁症减少 (p<0.05).
- IM@Home组的急性医疗利用率显著降低,包括ED访问和住院的次数减少 (p<0.05).
结论:
- 数字整合医学计划 (IM@Home) 有效地管理癌症患者的疲劳和并发症症状.
- IM@Home展示了在癌症治疗期间减少医疗保健利用的潜力.
- 通过III期临床试验进行进一步验证是有必要的,以证实这些有希望的发现.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


